Gliclazide Retard Viatris 30 mg
As listed in the register: Gliclazide Retard Viatris 30 mg, tabletten met gereguleerde afgifte
30 mg · tablet met gereguleerde afgifte
- Prescription only
- Digestion, stomach, diabetes and nutrition
- Active substance
- Gliclazide
- Made by
- Viatris Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria5 matching products
Spain15 matching products
- DIAMICRON 30 mg · comprimido de liberación modificada
- GLICLAZIDA AUROVITAS 30 mg · comprimido de liberación modificada
- GLICLAZIDA CINFA 30 MG · comprimido de liberación modificada
- GLICLAZIDA COMBIX 30 mg · comprimido de liberación modificada
- GLICLAZIDA KRKA 30 mg · comprimido de liberación modificada
- GLICLAZIDA NORMON 30 mg · comprimido de liberación modificada
- GLICLAZIDA SANDOZ 30 mg · comprimido de liberación modificada
- GLICLAZIDA STADA 30 MG · comprimido de liberación modificada
France9 matching products
- GLICLAZIDE ARROW LAB 30 mg · comprimé à libération modifiée
- GLICLAZIDE BGR 30 mg · comprimé à libération modifiée
- GLICLAZIDE EG LABO LABORATOIRES EUROGENERICS 30 mg · comprimé à libération modifiée
- GLICLAZIDE KRKA 30 mg · comprimé à libération modifiée
- GLICLAZIDE SANDOZ 30 mg · comprimé à libération modifiée
- GLICLAZIDE TEVA 30 mg · comprimé à libération modifiée
- GLICLAZIDE VIATRIS 30 mg · comprimé à libération modifiée
- GLICLAZIDE ZENTIVA 30 mg · comprimé à libération modifiée
Canada8 matching products
- AG-GLICLAZIDE MR 30 mg · tablet (extended-release)
- APO-GLICLAZIDE MR 30 mg · tablet (extended-release)
- DIAMICRON MR 30 mg · tablet (extended-release)
- GLICLAZIDE MR TABLETS 30 mg · tablet (extended-release)
- JAMP GLICLAZIDE-MR 30 mg · tablet (extended-release)
- MINT-GLICLAZIDE MR 30 mg · tablet (extended-release)
- MYLAN-GLICLAZIDE MR 30 mg · tablet (extended-release)
- TARO-GLICLAZIDE MR 30 mg · tablet (extended-release)
SwitzerlandNo exact match for this strength and form
Details
| Made by | Viatris Limited |
|---|---|
| Active substance | Gliclazide |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 30 mg |
| Form | tablet met gereguleerde afgifte |
| Classification | A10BB09 · Digestion, stomach, diabetes and nutrition |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Gliclazide Retard Viatris 30 mg, tabletten met gereguleerde afgifte |
| RVG | 34590 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.